Prospective - Funding confirmed

COG

Randomised phase III trial of gefitinib 500 mg once daily versus placebo in oesophageal cancer progressing after chemotherapy.
(click here for details)

FOXFIRE

An open-label randomised phase II trial of 5-Fluorouracil, OXaliplatin and Folinic acid +/- Interventional Radio-Embolisation as first line treatment of patients with liver dominant metastatic disease from colorectal cancer.
(click here for details)

DATACAP

Dose Adaption of Capecitabine Using Mobile Phone Toxicity Monitoring: A Pilot Study of Optimal Dose Scheduling of Capecitabine for Patients with Metastatic Colorectal or Metastatic Breast Cancer
(click here for details)